Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01551693
What this trial is testing

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 3
Not applicableStudy completedNCT00828126
What this trial is testing

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 38
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Early research (Phase 1)Study completedNCT02032810
What this trial is testing

Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma

Who this might be right for
MelanomaSkin Cancer
H. Lee Moffitt Cancer Center and Research Institute 17
Not applicableLooking for participantsNCT07379138
What this trial is testing

Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients

Who this might be right for
Melanoma
Mayo Clinic 350
Large-scale testing (Phase 3)Study completedNCT01227889
What this trial is testing

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

Who this might be right for
Cancer
GlaxoSmithKline 251
Testing effectiveness (Phase 2)Study completedNCT02941744
What this trial is testing

A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases

Who this might be right for
Stage IIIC Skin MelanomaStage IV Skin Melanoma
Universitair Ziekenhuis Brussel 56
Testing effectiveness (Phase 2)Ended earlyNCT01533948
What this trial is testing

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Ended earlyNCT02009384
What this trial is testing

Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox

Who this might be right for
Metastatic Melanoma
University of Louisville 2
Not applicableActive Not RecruitingNCT04056247
What this trial is testing

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung Cancer+2 more
OncoHost Ltd. 10,000
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01024231
What this trial is testing

Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant Melanoma
Bristol-Myers Squibb 127
Early research (Phase 1)Study completedNCT01008527
What this trial is testing

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 22
Testing effectiveness (Phase 2)Ended earlyNCT02359851
What this trial is testing

Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

Who this might be right for
Stage IIIA Uveal MelanomaStage IIIB Uveal MelanomaStage IIIC Uveal Melanoma+1 more
Vanderbilt-Ingram Cancer Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03122522
What this trial is testing

Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

Who this might be right for
Metastatic Melanoma
Memorial Sloan Kettering Cancer Center 70
Not applicableUnknownNCT00450593
What this trial is testing

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

Who this might be right for
Hereditary Multiple MelanomaMelanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT01840007
What this trial is testing

Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

Who this might be right for
Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)
Centre Hospitalier Universitaire de Nice 20
Early research (Phase 1)Study completedNCT01638533
What this trial is testing

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999749
What this trial is testing

A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 71
Next Page